Tomoko Oeda

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Astrocyte-vascular interactions are disturbed in cerebral white matter of adult-onset neuronal intranuclear inclusion disease.

Astrocyte-vascular interactions are disturbed in cerebral white matter of adult-onset neuronal intranuclear inclusion disease.

Journal: Journal of neuropathology and experimental neurology

Published: February 06, 2026

Drug-Induced Lupus Erythematosus After 14 Years of Carbamazepine Use in a Patient With Neuromyelitis Optica Spectrum Disorder: A Case Report.

Drug-Induced Lupus Erythematosus After 14 Years of Carbamazepine Use in a Patient With Neuromyelitis Optica Spectrum Disorder: A Case Report.

Journal: The American journal of case reports

Published: December 18, 2025

Hallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson's disease.

Hallucinations and cognitive impairment are associated with blood pressure fluctuations in Parkinson's disease.

Journal: BMJ neurology open

Published: December 03, 2025

Cortical involvement of lateral trunk flexion and verticality misperception in Parkinson's disease.

Cortical involvement of lateral trunk flexion and verticality misperception in Parkinson's disease.

Journal: Brain communications

Published: December 18, 2023

Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.

Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.

Journal: Multiple sclerosis and related disorders

Published: November 30, 2021

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial.

Journal: Expert opinion on pharmacotherapy

Published: September 02, 2020

Seeking transpaRINcy for rituximab dosing in NMOSD - Authors' reply.

Seeking transpaRINcy for rituximab dosing in NMOSD - Authors' reply.

Journal: The Lancet. Neurology

Published: June 27, 2020

Factors affecting relapse rate in patients with neuromyelitis optica spectrum disorder - Authors' reply.

Factors affecting relapse rate in patients with neuromyelitis optica spectrum disorder - Authors' reply.

Journal: The Lancet. Neurology

Published: May 18, 2020

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Neurology

Published: November 18, 2019

Pharmacological interventions for anxiety in Parkinson's disease sufferers.

Pharmacological interventions for anxiety in Parkinson's disease sufferers.

Journal: Expert opinion on pharmacotherapy

Published: June 26, 2018

Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.

Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 28, 2018

Low body mass index and life prognosis in Parkinson's disease.

Low body mass index and life prognosis in Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: December 18, 2017

Showing 1-12 of 37

Last Updated: 09/26/2026